Navigation Links
New study finds resistant organisms at core of soft contact lens corneal infections
Date:1/28/2008

In 2006, Bausch & Lomb withdrew its ReNu with MoistureLoc contact lens solution because a high proportion of corneal infections were associated with it. Now in a new study from University Hospitals Case Medical Center, researchers show that these infections were fueled and made resistant to treatment by the formation of a highly resistant structure of microbial cells held together with a glue-like matrix material. Scientists call this conglomeration of cells biofilms.

Once they live in that type of state, the cells become resistant to lens solutions and immune to the bodys own defense system, said Mahmoud A. Ghannoum, Ph.D., director of the Center for Medical Mycology at University Hospitals Case Medical Center and senior investigator of the study which appears in the January 2008 issue of the journal Antimicrobial Agents and Chemotherapy. This study should alert contact lens wearers to the importance of proper care for contact lenses to protect against potentially virulent eye infections, he said.

Biofilms are a constellation of resistant organisms, Dr. Ghannoum said. They were suspected with the spate of infections in 2005-2006, but until this study, there were no data to prove this. This is the first in-vitro model for cornea keratitis infections caused by the fungus Fusarium, which was one of the main culprits in the ReNu with Moisture Loc cases, and another fungus called Candida albicans.

The researchers also discovered that the strain of fungus (ATCC 36031) used for testing the effectiveness of lens care solutions is a strain that does not produce biofilms as the clinical fungal strains do. Lens care solutions currently are tested against an old and rare genotype fungal strain obtained in the 1970s from a patient from Nigeria. The contact lens solutions, therefore, are effective in the laboratory, but fail when faced with strains in real-world situations. The multipurpose contact lens solutions cannot kill these germ
'/>"/>

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-3667
University Hospitals of Cleveland
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Feds fund study of drug that may prevent radiation injury
2. Study examines self-expanding plastic stents in the treatment of benign esophageal conditions
3. Amalgam Fillings Dont Affect Childrens Brain Development, Says Study in ADA Journal
4. Amalgam fillings dont affect childrens brain development, says study in ADA Journal
5. Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds
6. From Research to Practice: Healthfitness, Eastman Chemical Company Case Study Demonstrates Real-World Health Gains and Productivity Savings
7. Study raises questions about diagnosis, medical treatment of ADHD
8. Another Study Links Western Diet to Heart, Health Risks
9. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
10. New Kaiser Permanente study fortifies caffeines link to miscarriage
11. Kaiser Permanente study shows link between caffeine and miscarriage

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., December 4, 2009 -- Substantial progress has bee...mmunity,s ability to diagnose and treat epilepsy a...sy management has not reached most of the 50 milli...nearly three million people in the United States w...chachter, M.D., president of the American Epilepsy...
(Date:12/4/2009)...the first indication they understand what 2-D imag..., Dec. 4 (HealthDay News) -- Monkeys can recognize...hat they can both detect differences in faces and ...s report. , The study also shows that capuchin ... a photograph, the scientists authors noted. , ...
(Date:12/4/2009)..., LOS ANGELES, Dec. 4 Yogen Fru..., announced today the launch of its holiday themed... On December 7, the new festive mixes will be unve...gen Fruz,s low-calorie Yog-Nog and Mint Chocolate ...sert alternative to indulge in this holiday season...
(Date:12/4/2009)... InhibOx, a leading developer of...g discovery, has joined forces with MolPort, an in...on developing rare chemical trading platform and b.... Now we provide this database and its updates to ...porate it into the virtual screening procedures. O...
(Date:12/4/2009)... Best-Selling author and Personal...cuss Organizational Transformation through Account...CA (PRWEB) December 4, 2009 -- IMPAQ Accountabil...hat Mark Samuel , best-selling Author, renowned S...ity Business Consultants Inc., will present at the...
Breaking Medicine News(10 mins):Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4Health News:Yogen Fruz Introduces New Holiday Flavors: Yog-Nog and Mint Chocolate Chip 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference 2
...e of path breaking news that suggests possible l...ia. // Reduced vitamin D levels in the mother d...e onset of this disorder, according to the resear...ink between Schizophrenia and Vitamin D. Dr Darryl...
...n England have revealed that if patients who are u...tment and taught to scale down the risk of blood c... Those patients who change the doses of warfarin, ...omparison to those who are being monitored by medi...
...h which 3-month-old Jason Wolfe received a lung tr...by received a heart // transplant in Ohio. The sur...d away, and its organs were compatible to the two ...ted to Kayla. This was considered safe as a lung t...
...re prone to go in for substance abuse when compare...nters will be established at some of the shelters ...Rapid HIV testing for women who are homeless and d...ol, AIDS, and drugs. Mental illness among the home...
...ers for Disease Control and Prevention said that a...ave developed // resistance to adamantanes, the cl...lu infection. Drugs belonging to this class li...nal of the American Medical Association. Amantadi...
... womb. A new study has shown that by detecting the...tors can predict the risk of delivering a pre-term...re infections. // Dr Catalin Buhimschi of Yale...hese were obtained from women who delivered pre-te...
Other Medicine News:Health News:Sunny Side Up - Vitamin-D deficiency linked to Schizophrenia 2Health News:Resistant Influenza strains creates panic in US 2
(Date:12/4/2009)... , TARRYTOWN, N.Y., Dec. 4 Bay...rize winners of Bayer,s "Express Your Simple Win C...ers, selected the winning video entries submitted ... The grand prize is an in-person meeting today wit...tes like Nick, are: Caleb, age 6, from Danbury, CT...
(Date:12/4/2009)..., BETHESDA, Md., Dec. 4 ...mpany") (OTC Bulletin Board: NWBO) announced today...ed its patent application on a system for automati... Company,s DCVax® therapeutic cancer vaccines...he very high concentration of dendritic cells (whi...
(Date:12/4/2009)..., RARITAN, N.J., Dec. 4 Depressi...Deficit Hyperactivity Disorder (ADHD), sleep disor...s reported to occur more often in people who said ... without an epilepsy diagnosis, according to a sur... U.S. ,, Findings from " CNS-Related Comorbidit...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Study shows link between influenza virus and fever 10734 1Study shows link between influenza virus and fever 10734 2Heavy Snoring Linked To Potentially Life Threatening Conditions 61417 1Heavy Snoring Linked To Potentially Life Threatening Conditions 61417 2Heavy Snoring Linked To Potentially Life Threatening Conditions 61417 3Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 1Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 2Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 3Hollis Eden Presents New Interim Data From Prostate Cancer Phase I II Clinical Studies of Apoptone 28HE3235 29 at AACR Molecular Targets and Cancer T 14849 4
...d for competent industry professionals, Northweste...rogram in Clinical Research and Regulatory,Adminis.../ ., Northwestern University School of Continuing...niversity Clinical and Translational,Sciences Inst...pring with a,Feb. 22, 2008, application deadline a...
...M), a developer of follow-on biologics and biophar...a broad education campaign on the importance,of es...rge molecule,protein-based drugs, known as follow-...red to as biosimilars or biogenerics., The scient...oval of,small-molecule generic drugs is well devel...
Other Medicine Technology:Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program 2Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics 2Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics 3
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
Medicine Products: